Polypid Ltd (PYPD) Return on Assets ROA from the second quarter of 2025 to second quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Jun 30 2025 to 0 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Polypid Ltd  (NASDAQ: PYPD)


Polypid Ltd's ROA from the second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Polypid Ltd's ROA in the second quarter of 2025?
Polypid Ltd achieved a return on average assets (ROA) of 30.01 % in its second quarter of 2025, this is above PYPD's average return on assets of -26.03%.
Polypid Ltd assets over the 12 months ending in its second quarter of 2025 are valued at $63 million

ROA decreased relative to the period ending Dec 31 2024, due to the decline in net income.

However, within the Healthcare sector 975 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2024 from to 50.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2025)
II. Quarter		 (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Total Assets Change 439.51 % 72.79 % 35.5 % 3.54 % -69.3 %
Y / Y Net Income Change - 397.21 % - - -
Net Income (TTM) in million 19 29 6 45 45
Return On Assets (TTM) 30.01 % 69.18 % 15.62 % 141.16 % 142.11 %
PYPD's Total Ranking # 50 # # # # 39
Total Assets (TTM) in million 106 44 79 25 20
Seq. Total Assets Change 142.36 % -45.14 % 214.93 % 28.83 % -22.38 %
Seq. Net Income Change - - - - -

PYPD's 5 Years Annual ROA >> Back to PYPD Management Effectiveness >> Compare PYPD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 206
Sector # 976
Overall # 5323

Return On Assets Statistics
High Average Low
156.56 %
-26.03 %
-153.18 %
(Dec 31 2023)   (Dec 31 2025)





Financial Statements
Polypid Ltd's Assets $ 106 million PYPD's Balance sheet
Polypid Ltd's Income $ -10 million Quarterly PYPD's Income Statement
PYPD's Income by Division See PYPD's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 14.09 % 35.5 % -8.83 % -8.36 % -0.41 %
Total Assets in million 91 79 59 64 70
Y / Y Net Income Change - 20.59 % - - -
Net Income in million -34 29 24 -40 -43
Annual Return On Assets -37.71 % 36.54 % 41.06 % -61.52 % -60.72 %

PYPD's 5 Years Annual ROA >> Back to PYPD Management Effectiveness >> Compare PYPD ROA to its Competitors



More Return On Assets Ratios
PYPD's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PYPD's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PYPD's Competitors
Subscribers only: Roa for Polypid Ltd's Suppliers
Subscribers only: Return On Assets for PYPD's Customers

You may also want to know
PYPD's Roi PYPD's Inventory Turnover Ratio PYPD's Growth Rates PYPD's Dividend Comparisons
PYPD's Profitability Ratios PYPD's Asset Turnover Ratio PYPD's Dividend Growth
PYPD's Roe PYPD's Valuation Ratios PYPD's Financial Strength Ratios PYPD's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector ROA
Rigel Pharmaceuticals Inc  57.03 %
Seres Therapeutics Inc   54.88 %
Gridai Technologies Corp  53.25 %
Exelixis Inc   48.25 %
Earth Science Tech Inc   44.59 %
Adma Biologics Inc   42.90 %
Coherus Oncology inc   40.76 %
Entera Bio Ltd   40.32 %
Agios Pharmaceuticals Inc   40.12 %
Abeona Therapeutics Inc   39.81 %
Biomx Inc  39.73 %
Dariohealth Corp   39.03 %
Stablecoin Development Corporation  38.52 %
Interpace Biosciences Inc   37.22 %
Cytomx Therapeutics Inc   36.01 %
Medinotec Inc   35.97 %
Siga Technologies Inc  35.65 %
Edwards Lifesciences Corporation  31.53 %
Synlogic Inc   31.51 %
Minerva Neurosciences Inc   31.37 %
Idexx Laboratories Inc  29.89 %
Novavax inc   28.65 %
Ptc Therapeutics inc   28.48 %
Nutriband Inc   26.59 %
Halozyme Therapeutics Inc   26.44 %
Rafael Holdings Inc  25.88 %
Mettler toledo International Inc   25.15 %
Longduoduo Co Ltd  24.60 %
Sbc Medical Group Holdings Incorporated  24.51 %
Catalyst Pharmaceuticals Inc   23.82 %

Date modified: 2026-07-07T12:42:51+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.